Animal studies analyzed in the present review outlined a clear picture that ACEI/ARB treatments can cause ACE2 upregulation with consequential beneficial effects considering either cardiovascular disorders or lung injury. The gene discussed is ACE2; the disease is cardiovascular disorder.